Tanikawa C - Search Results

1

Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.

Shiraishi K, Fukuda S, Mori T, Matsuda K, Yamaguchi T, Tanikawa C, Ogawa M, Nakamura Y, Arakawa H. Shiraishi K, et al. Among authors: tanikawa c. Cancer Res. 2000 Jul 15;60(14):3722-6. Cancer Res. 2000. PMID: 10919640

2

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y. Oda K, et al. Among authors: tanikawa c. Cell. 2000 Sep 15;102(6):849-62. doi: 10.1016/s0092-8674(00)00073-8. Cell. 2000. PMID: 11030628 Free article.

3

p53RDL1 regulates p53-dependent apoptosis.

Tanikawa C, Matsuda K, Fukuda S, Nakamura Y, Arakawa H. Tanikawa C, et al. Nat Cell Biol. 2003 Mar;5(3):216-23. doi: 10.1038/ncb943. Nat Cell Biol. 2003. PMID: 12598906

4

RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest.

Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J. Saigusa K, et al. Among authors: tanikawa c. Oncogene. 2007 Feb 22;26(8):1110-21. doi: 10.1038/sj.onc.1210148. Epub 2006 Dec 4. Oncogene. 2007. PMID: 17146433

5

CDC20, a potential cancer therapeutic target, is negatively regulated by p53.

Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K. Kidokoro T, et al. Among authors: tanikawa c. Oncogene. 2008 Mar 6;27(11):1562-71. doi: 10.1038/sj.onc.1210799. Epub 2007 Sep 17. Oncogene. 2008. PMID: 17873905

6

Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.

Shimo A, Tanikawa C, Nishidate T, Lin ML, Matsuda K, Park JH, Ueki T, Ohta T, Hirata K, Fukuda M, Nakamura Y, Katagiri T. Shimo A, et al. Among authors: tanikawa c. Cancer Sci. 2008 Jan;99(1):62-70. doi: 10.1111/j.1349-7006.2007.00635.x. Epub 2007 Oct 18. Cancer Sci. 2008. PMID: 17944972 Free PMC article.

7

Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma.

Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, Araki N, Kudawara I, Ieguchi M, Nakamura K, Nakamura Y, Matsuda K. Morioka K, et al. Among authors: tanikawa c. Cancer Sci. 2009 Jul;100(7):1227-33. doi: 10.1111/j.1349-7006.2009.01165.x. Epub 2009 Apr 15. Cancer Sci. 2009. PMID: 19486338 Free PMC article.

8

XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway.

Tanikawa C, Furukawa Y, Yoshida N, Arakawa H, Nakamura Y, Matsuda K. Tanikawa C, et al. Oncogene. 2009 Aug 27;28(34):3081-92. doi: 10.1038/onc.2009.154. Epub 2009 Jun 22. Oncogene. 2009. PMID: 19543321

9

Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.

Tanikawa C, Ueda K, Nakagawa H, Yoshida N, Nakamura Y, Matsuda K. Tanikawa C, et al. Cancer Res. 2009 Nov 15;69(22):8761-9. doi: 10.1158/0008-5472.CAN-09-2280. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843866

10

Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway.

Tanikawa C, Ri C, Kumar V, Nakamura Y, Matsuda K. Tanikawa C, et al. Mol Cancer Res. 2010 Jun;8(6):855-63. doi: 10.1158/1541-7786.MCR-09-0484. Epub 2010 May 25. Mol Cancer Res. 2010. PMID: 20501644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters